Laboratorio Reig Jofre - About the company
Laboratorio Reig Jofre is a public company based in Barcelona (Spain), founded in 2000. It operates as a Manufacturer of pharmaceutical products and food supplements. Laboratorio Reig Jofre has raised an undisclosed amount in funding. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.
Company Details
Manufacturer of pharmaceutical products and food supplements. This company researches, develops, manufactures, and markets these products, specializing in sterile injectables, lyophilized products, penicillin-derived antibiotics, dermatology and osteoarticular treatments, and consumer healthcare products. It operates development and production centers and has subsidiaries and business partners globally. The company's focus is on providing solutions across pharmaceutical technologies and consumer healthcare.
- Website
- reigjofre.com/en/
- Registered Address
- UNIT 9A CADDSDOWN BUSINESS SUPPORT CENTRE,CADDSDOWN INDUSTRIAL PARK,BIDEFORD,DEVON,ENGLAND,EX39 3DX
Key Metrics
Founded Year
2000
Location
Barcelona, Spain
Stage
Public
Latest Funding Round
Ranked
9th among 1239 active competitors
Annual Revenue
£1M - £10M as on Dec 31, 2022
Employee Count
913 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Laboratorio Reig Jofre
Laboratorio Reig Jofre is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
REIG JOFRE UK LIMITED CIN: 9301085 , United Kingdom, Active | Nov 06, 2014 | £1M - £10M (As on Dec 31, 2022) | 2 (As on Dec 31, 2024) |
Laboratorio Reig Jofre's IPO details
Laboratorio Reig Jofre got listed on Jun 21, 2024.
Click here to take a look at Laboratorio Reig Jofre's IPO in detail
Sign up to download Laboratorio Reig Jofre's company profile
Laboratorio Reig Jofre's funding and investors
Laboratorio Reig Jofre has raised funding over 3 rounds. Its first funding round was on Apr 01, 2021. Its latest funding round was a Grant (prize money) round on May 09, 2025 for $*****. 1 investor participated in its latest round. Laboratorio Reig Jofre has 2 institutional investors.
Here is the list of recent funding rounds of Laboratorio Reig Jofre:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 09, 2025 | 9520083 | Grant (prize money) | 8056660 | 8343093 | 3551443 | 7352254 |
Jun 27, 2023 | 9680603 | Grant (prize money) | 6957568 | 7336054 | 4211416 | |
Apr 01, 2021 | 9064710 | Grant (prize money) | 9156045 | 2250348 | 1190579 |
Access funding benchmarks and valuations. Sign up today!View details of Laboratorio Reig Jofre's funding rounds and investors
Laboratorio Reig Jofre's founders and board of directors
Founder? Claim ProfileLaboratorio Reig Jofre's employee count trend
Laboratorio Reig Jofre has 913 employees as of Sep 26. Here is Laboratorio Reig Jofre's employee count trend over the years:
Uncover Laboratorio Reig Jofre's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Laboratorio Reig Jofre's Competitors and alternates
Top competitors of Laboratorio Reig Jofre include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Laboratorio Reig Jofre, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd |  Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public | Traditional company engaged in manufacturing generics | $500M | 75/100 | |
3rd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
4th |  Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
5th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
6th | The Alvogen 2009, Morristown (United States), Acquired | Developer and marketer of pharmaceutical products | $156M | 69/100 | |
7th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
8th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
9th | Laboratorio Reig Jofre 2000, Barcelona (Spain), Public | Manufacturer of pharmaceutical products and food supplements | - | 68/100 | |
10th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Laboratorio Reig Jofre's competitors? Click here to see the top ones
Laboratorio Reig Jofre's Investments and acquisitions
Laboratorio Reig Jofre has made 2 investments in companies including Affirma Biotech and Affirma Biotech. Laboratorio Reig Jofre has also acquired 5 companies including Leanbio and Bioglan.Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Dec 02, 2025 | Acquisition | 2014 | Barcelona (Spain) | |
Feb 01, 2024 | Investments | 2020 | Barcelona (Spain) | |
Sep 19, 2022 | Investments | 2020 | Barcelona (Spain) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Laboratorio Reig Jofre
News related to Laboratorio Reig Jofre
Filter this listMedia has covered Laboratorio Reig Jofre for a total of 7 events in the last 1 year, 2 of them have been about company updates.
•
Reig Jofre Approves Dividend and Series B Shares, Aims for Growth and European AcquisitionsPressDigital•May 07, 2026•Laboratorio Reig Jofre
•
Reig Jofre to Increase Revenue by €25 Million with Leanbio AcquisitionExpansion•Mar 10, 2026•Leanbio, Laboratorio Reig Jofre
•
Laboratorios Reig Jofre's Profit Decreased by 52% Due to Lower Production of AntibioticsExpansion•Feb 28, 2026•Laboratorio Reig Jofre
•
Reig Jofre reduces its profit by 52% in 2025 due to the acquisition of LeanbioBolsamania•Feb 27, 2026•Laboratorio Reig Jofre
•
Reig Jofre invests 3.5 million to increase its stake in Leanbio to 85%Bolsamania•Dec 02, 2025•Leanbio, Laboratorio Reig Jofre
•
Reig Jofre reduces profits and sales due to lower productionExpansion•Nov 06, 2025•Laboratorio Reig Jofre
•
Reig Jofre to receive €13 million to boost pharmaceutical innovationEstrategiasdeinversion•May 09, 2025•Laboratorio Reig Jofre
•
Reig Jofre will receive a 13 million euro grant to boost pharmaceutical innovation.PressDigital•May 08, 2025•Laboratorio Reig Jofre, CDTI
•
Reig Jofre and Leo Pharma join forces to improve access to an innovative psoriasis treatment in primary carePharmatech industria farmaceutica•Mar 27, 2025•Leo Pharma, Laboratorio Reig Jofre
•
Reig Jofre earns 2% more after raising sales to 253 millionExpansion•Nov 01, 2024•Laboratorio Reig Jofre
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Laboratorio Reig Jofre
Explore our recently published companies
- Aller Travel - Oslo based, Public company
- Alley Ford - Austin based, 2022 founded, Unfunded company
- Allegory Dance Theatre - Philadelphia based, Unfunded company
- Aligning Visions - Panama based, 2005 founded, Unfunded company
- Alexander Success - Brentwood based, 2014 founded, Unfunded company
- Albert Immo - Germany based, Unfunded company
